Study on the Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation Under Hilar Nerve Blockade
Phase: PHASE1, PHASE2 | Sponsor: The First Affiliated Hospital of Xiamen University | Compound: Ketamine
- Status
- active
- Institution
- The First Affiliated Hospital of Xiamen University
- Start date
- 2025-06-29
- End date
- 2028-06-30
- Registry ID
- NCT07034950
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.